The lab-made 3D liver model serves as a human relevant platform for analyzing the progressive stages of the liver disease, ...

Non-alcoholic fatty liver disease is becoming the most common chronic liver disorder in developed countries. Histological analysis of liver tissue is the only widely accepted test for diagnosing and ...

Non-alcoholic fatty liver disease is becoming the most common chronic liver disorder in developed countries. Histological analysis of liver tissue is the only widely accepted test for diagnosing and ...

Metabolic dysfunction--associated steatohepatitis or MASH (formerly known as nonalcoholic steatohepatitis) is an inflammatory, liver-scarring disease that affects 1.5% to 6.5% of all U.S. adults.

In a bid to gain further understanding of the etiology and pathogenesis of metabolic dysfunction–associated steatohepatitis (MASH), a team of researchers has created 3D bioprinted liver models. MASH, ...

As chronic liver disease becomes more widespread, researchers at Science Tokyo have developed a lab-grown organoid that ...

A new method of 3D printing an anatomically accurate replica of the human liver is now helping to guide surgeons during tricky procedures. The 3D-printed replicas, which are made of transparent ...

Mitochondrial impairment is a major mechanism of action (MoA) causing drug-induced liver injury (DILI), as evidenced by drugs that have received black box warnings, 1 such as Amiodarone (used to treat ...

Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced the publication of a seminal manuscript in ...

InSphero AG, the leading supplier of advanced, yet easy-to-use 3D cell culture-based solutions for drug discovery and development, today announced the launch of 3D InSight™ Monkey Liver Microtissues, ...